Stockscreener 앱 받기
0.8328
2.57%
-0.022
시간 외 거래:
.83
-0.0028
-0.34%
전일 마감가:
$0.8548
열려 있는:
$0.8315
하루 거래량:
345.37K
Relative Volume:
0.15
시가총액:
$16.37M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.1256
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
+2.68%
1개월 성능:
+40.15%
6개월 성능:
-85.13%
1년 성능:
-55.70%
1일 변동 폭
$0.8211
$0.8692
1주일 범위
$0.782
$0.8797
52주 변동 폭
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
명칭
iBio Inc
전화
302-355-0650
주소
600 Madison Avenue, Suite 1601, New York, NY
IBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.8328 | 16.80M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-28 | 개시 | Chardan Capital Markets | Buy |
| 2021-11-29 | 개시 | JMP Securities | Mkt Outperform |
| 2021-01-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 개시 | Alliance Global Partners | Buy |
iBio Inc 주식(IBIO)의 최신 뉴스
Big Picture: How cyclical is iBio Inc.’s revenue streamAnalyst Upgrade & Weekly Momentum Picks - Lancaster City Council
Is a relief rally coming for iBio Inc. holdersWeekly Profit Report & Technical Buy Zone Confirmations - Newser
iBio Full Year 2025 Earnings: US$1.75 loss per share (vs US$4.03 loss in FY 2024) - Yahoo Finance
What hedge funds are buying iBio Inc.July 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Can iBio Inc. be recession proofEarnings Overview Report & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Ibio Inc’s Future at Risk: Reliance on Third-Party Licenses for Key Product Candidates - TipRanks
iBio, Inc. Reports Transformative Fiscal Year 2025 - TipRanks
Brookline Capital Markets reiterates Buy rating on iBio stock with $1.60 target - Investing.com India
What MACD and RSI say about iBio Inc.Market Sentiment Review & Entry Point Confirmation Signals - Newser
Brookline Capital Markets reiterates Buy rating on iBio stock with $1.60 target By Investing.com - Investing.com South Africa
Why is iBio Inc. stock going upJuly 2025 Update & Risk Controlled Swing Trade Alerts - خودرو بانک
Is iBio Inc. trending in predictive chart modelsWeekly Trade Report & AI Enhanced Trade Execution Alerts - Newser
IBio, Inc. Reports Earnings Results for the Full Year Ended June 30, 2025 - MarketScreener
iBio, Inc. SEC 10-K Report - TradingView
iBio Sets Sights on Clinic for Treatments of Obesity, Heart Disease - San Diego Business Journal
iBio Reports Fiscal Year 2025 Financial Results and Provides Cor - GuruFocus
iBio (IBIO) Reports Revenue Growth and Strategic Advancements - GuruFocus
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - The Manila Times
Multi asset correlation models including iBio Inc.2025 Key Highlights & Entry Point Confirmation Alerts - Newser
26% Fat Loss Without Muscle Loss: iBio's New Obesity Drug IBIO-610 Shows Promise in Preclinical Data - Stock Titan
Does iBio Inc. fit your quant trading modelGap Down & Low Drawdown Momentum Ideas - Newser
Multi factor analysis applied to iBio Inc.Market Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Volatility clustering patterns for iBio Inc.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
Is iBio Inc. undervalued by DCF analysisInsider Selling & Entry Point Strategy Guides - خودرو بانک
What’s the analyst consensus on iBio Inc.Weekly Stock Recap & Growth Focused Investment Plans - خودرو بانک
What earnings revisions data tells us about iBio Inc.Weekly Trade Report & AI Enhanced Trade Execution Alerts - Newser
Is now a turning point for iBio Inc.July 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
Backtesting results for iBio Inc. trading strategiesJuly 2025 Technicals & Long-Term Safe Investment Ideas - Newser
Can technical indicators confirm iBio Inc.’s reversal2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with iBio Inc.Quarterly Investment Review & Precise Buy Zone Identification - Newser
Volume spikes in iBio Inc. stock – what they mean2025 Performance Recap & Consistent Income Trade Ideas - Newser
Using portfolio simulators with iBio Inc. includedEarnings Risk Report & Consistent Growth Equity Picks - Newser
What’s next for iBio Inc. stock priceWeekly Market Report & Precise Entry and Exit Recommendations - Newser
Is iBio Inc. forming a reversal patternJuly 2025 Sentiment & Expert Verified Movement Alerts - Newser
iBio Inc. stock daily chart insights2025 Momentum Check & Reliable Entry Point Trade Alerts - Newser
iBio Inc. stock chart pattern explained2025 Trading Recap & AI Forecast for Swing Trade Picks - Newser
Can iBio Inc. expand its profit marginsEarnings Overview Report & Daily Stock Trend Watchlist - خودرو بانک
How to escape a deep drawdown in iBio Inc.Analyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Can you recover from losses in iBio Inc.Breakout Watch & AI Based Buy/Sell Signal Reports - Newser
Will iBio Inc. benefit from AI trends2025 Short Interest & Accurate Entry and Exit Point Alerts - خودرو بانک
Is iBio Inc. a play on infrastructure spendingWeekly Gains Report & AI Enhanced Trading Alerts - خودرو بانک
Best data tools to analyze iBio Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - Newser
Is iBio Inc. attractive at current valuation2025 Growth vs Value & Weekly Top Gainers Alerts - خودرو بانک
Is iBio Inc. stock a hidden gemGDP Growth & Growth Focused Stock Pick Reports - خودرو بانک
Technical signs of recovery in iBio Inc.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
iBio Inc (IBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.96%
1.11%
자본화:
|
볼륨(24시간):